AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00151398 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lecozotan SR
Description: evaluation of long term therapy with 3 doses of lecozotan sr ( 2, 5, and 10 mg)administered to patients with AD who have completed week 12 evaluations in the short-term study. Patient duration is 42 weeks.~Arms include lecozotan sr 2 mg, 5mg, and 10 mg as well as donepezil.
Study NCT00151398 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Donepezil
Description: 10 mg donepezil QD dosed up to 40 weeks
Study NCT00518856 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neonatal resuscitation protocol
Description: training in neonatal resuscitation and sepsis identification early treatment
Study NCT00518856 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: continued with current standard of care for birth attendants
Study NCT01973140 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Tolvaptan
Description: Adult male volunteers will be given a given a 60mg or a 30 mg dose of tolvaptan. Blood and urine samples will be collected at specified time points for the next 24 hours.
Study NCT01973140 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Hypertonic saline infusion
Description: A week after the first intervention(tolvaptan), the subjects will undergo a hypertonic saline infusion for 6 hours. Blood and urine samples will be collected at specified time points until 4hour hours after the infusion.
Study NCT01598103 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAF312
Description: One week of treatment in a BID (two times a day) regimen (hard gelatin capsules for oral use)
Study NCT01598103 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to SAF312
Description: One week of treatment in a BID (two times a day) regimen (hard gelatin capsules for oral use)
Study NCT00629005 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Constraint-Induced Movement Therapy + strength training
Description: Participants wears a mitt on non-paretic hand for 90% of waking hours and completes 3 hours of functional task practice (e.g., flipping cards, putting coins in coin slot, putting cans on a shelf) plus 1 hour of resistance elastic band exercises
Study NCT00629005 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Constraint-Induced Movement Therapy + range of motion
Description: Participants wears a mitt on non-paretic hand for 90% of waking hours and completes 3 hours of functional task practice (e.g., flipping cards, putting coins in coin slot, putting cans on a shelf) plus 1 hour of unresisted arm movements for
Study NCT02617979 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SAFECARE at Home customized lessons
Study NCT01063894 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: breakfast cereal
Description: breakfast cereal and milk
Study NCT01063894 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: water
Description: water
Study NCT01836185 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Evacetrapib
Study NCT03703726 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Reference meal
Description: 50 g of Commercial Rice (Jasmin Rice) (dry weight) was cooked and 4 mg iron from Ferrous sulphate was added Prior to give to participants. Rice meal consumed with mixed vegetable Sauce.
Study NCT03703726 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Test meal A
Description: Commercial Rice (Jasmin Rice) was mixed with iron fortified extruded rice co-fortified with zinc sulfate, Rice meal consumed with mixed vegetable Sauce.~Cold temperature extruding process (30-40 C°) was used to produce the extruded rice.
Study NCT03703726 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Test meal B
Description: Commercial Rice (Jasmin Rice) was mixed with iron fortified extruded rice co-fortified with zinc sulfate, Rice meal consumed with mixed vegetable Sauce.~Warm temperature extruding process (60-70 C°) was used to produce the extruded rice
Study NCT03703726 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Test meal C
Description: Commercial Rice (Jasmin Rice) was mixed with iron fortified extruded rice co-fortified with zinc sulfate, Rice meal consumed with mixed vegetable Sauce.~Hot temperature extruding process (80-100 °C) was used to produce the extruded rice.
Study NCT03703726 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Test meal D
Description: Commercial Rice (Jasmin Rice) was mixed with iron fortified extruded rice co-fortified with zinc sulfate,citric acid and trisodium Citrate. Rice meal consumed with mixed vegetable Sauce.~Cold temperature extruding process (30-40 C°) was used to produce the extruded rice.
Study NCT03703726 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Test meal E
Description: Commercial Rice (Jasmin Rice) was mixed with iron fortified extruded rice co-fortified with zinc sulfate,citric acid and trisodium Citrate. Rice meal consumed with mixed vegetable Sauce.~warm temperature extruding process (60-70 C°) was used to produce the extruded rice.
Study NCT03703726 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Test meal F
Description: Commercial Rice (Jasmin Rice) was mixed with iron fortified extruded rice co-fortified with zinc sulfate,citric acid and trisodium Citrate. Rice meal consumed with mixed vegetable Sauce.~Hot temperature extruding process (80-100 C°) was used to produce the extruded rice.
Study NCT04654962 — intervention group
Intervention type: PROCEDURE
Intervention: Anesthetic nerve block
Description: iliac fascia block is an analgesic technique that uses local anesthesia, is effective and relatively safe in preoperative management. The target of this block is the femoral and lateral femoral cutaneous nerves; which innervate the anterior aspect of the thigh, as well as the muscle and periosteum that covers the femoral head, neck and proximal femur.
Study NCT03085199 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Laparoscopic reinforcement suture
Description: After cutting of duodenal stump of about 2 cm length using linear stapler, LARS commenced from upper to lower part on staple-line of duodenal stump. Continuous suture with invagination was performed using a barbed suture. In case of patient with short duodenal stump because of chronic ulcer or ectopic pancreas at duodenal bulb, 2 or 3 interrupted sutures without invagination of duodenal stump was conducted using barbed sutures.
Study NCT03069144 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HAT1 topical solution
Description: HAT1 topical solution will be applied twice daily. The research team will provide instructions for the correct application of the treatment. If a lesion disappears, patients will continue applying the cream twice daily to the area. No additional creams, lotions or soaps other than provided test products will be allowed throughout the duration of the study.
Study NCT03069144 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Calcipotriol
Description: Calcipotriol ointment (0.005%) will be applied twice daily. The research team will provide instructions for the correct application of the treatment. If a lesion disappears, patients will continue applying the cream twice daily to the area. No additional creams, lotions or soaps other than provided test products will be allowed throughout the duration of the study.
Study NCT01134471 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ostene
Description: applied to sternal surface
Study NCT01134471 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bonewax
Description: applied to sternal surface
Study NCT02907619 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PF-06252616
Description: Either 5mg/kg, 20mg/kg or 40mg/kg will be assigned to a subject based on their maximum tolerated dose from B5161002
Study NCT04012346 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial magnetic stimulation
Description: Transcranial magnetic stimulation device will be used. Short protocol iTBS will be applied.
Study NCT04012346 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial magnetic stimulation
Description: Transcranial magnetic stimulation device will be used. Short protocol iTBS will be applied.
Study NCT04043208 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Biofeedback
Description: Three sessions of biofeedback will be performed during the first 3 weeks of the intervention period. Biofeedback sessions will be performed 30 min after ingestion of the offending meal: patients will be taught to control abdominal and thoracic muscular activity by providing a visual display of the abdominal and thoracic perimeter; specifically, they will be instructed to reduce the abdominal perimeter (girth). Patients will be instructed to perform the same exercises before and after breakfast, lunch and dinner during the 4-week intervention period.
Study NCT01124071 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Provision of 2 Korean meals per day 6 days per week
Description: At each participant's baseline visit, participant's will have an individualised lifestyle session addressing dietary and exercise goals and techniques to achieve weight loss. Participants in the Korean diet group will pick up lunch and evening meals Monday-Friday. Raw ingredients and cooking instructions will also be provided on friday for saturday meal preparation. Ongoing lifestyle sessions will be performed weekly for participants.
Study NCT01124071 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Western Diet
Description: At each participant's baseline visit, participant's will have an individualised lifestyle session addressing dietary and exercise goals and techniques to achieve weight loss. Participants in the Western diet group will be provided with a Western recipe cookbook and food vouchers (weekly) to purchase the necessary ingredients for the Western meal preparation. Ongoing lifestyle sessions will be performed weekly for participants.
Study NCT00907192 — intervention group
Intervention type: BEHAVIORAL
Intervention: Personal Interview
Description: Interview questions about use of pain drugs and other knowledge and/or attitudes about them. Take about 5-10 minutes to complete.
Study NCT00907192 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionnaire
Description: 5 short questionnaires about use of pain drugs, attitudes about the pain drugs and their use, and concerns about use of these pain drugs. Take about 10-15 minutes to complete.
Study NCT01240889 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluticasone
Description: nasal spray
Study NCT01240889 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluticason
Description: 2 sprays per day in each nostril
Study NCT04544865 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Staple Line Reinforcement
Description: ENDOPATH ECHELON Staple Line Reinforcement is used for reinforcement of staple lines during lung resection and bariatric surgical procedures, according to instructions for use.
Study NCT04043208 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Three sessions will be performed during the first 3 weeks of the intervention period. Each session will be performed 30 min after ingestion of the offending meal: abdominal and thoracic perimeter will be recorded but not shown to the patient; patients will take a pill of placebo containing 0.5 g glucose and no specific instructions will be provided. Patients will be instructed to take a pill of placebo before breakfast, lunch and dinner during the 4-week intervention period.
Study NCT00508157 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Description: Tablets, Oral, 5 to 30 mg, once daily, 16 weeks
Study NCT00508157 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Continued Antipsychotic (Risperidone or Quetiapine or Olanzapine)
Description: Tablets, Oral, According to summary of product characteristics (SmPC)
Study NCT04448639 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Echocardigraphy (ECHO)
Description: Standar 12 lead electrocardiogram
Study NCT04448639 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Bloodtest
Description: cardiac biomarkers
Study NCT03373851 — intervention group
Intervention type: DEVICE
Intervention: Zalviso Device
Description: The Zalviso device will be provided immediately before the Post anesthesia care unit (PACU) discharge. Patients will be queried every day during three postoperative days for the ability to use the device, their satisfaction, the level of pain, and the incidence of side effects. There will be no changes in usual care.~In the end of this study ward nurses carrying Zalviso patients will be asked to provide their usability and satisfaction evaluation for Zalviso device management. Physical therapist will be asked to provide their satisfaction regarding patients' ability to follow physical therapy program.
Study NCT01704443 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group Psychoeducational Treatment
Description: The Group Psychoeducational Treatment consists of treatment in small group format (8-9 women). Each session will be 2.25 hours in duration and there will be four, bi-weekly sessions over the course of 2 months. Session content includes education about chronic pain, PVD, stress and sexual response, mindfulness practices, and cognitive techniques to notice thought patterns that contribute to increased pain.~Participants in the Waitlist Control Condition will receive this treatment at the end of the waitlist period (approximately 8 weeks)
Study NCT01704443 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Waitlist control
Description: No treatment will be provided during the 8 week Waitlist control period
Study NCT00979693 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: psilocybin
Description: 25 mg psilocybin administered orally once during each of the two day-long psychotherapy sessions.
Study NCT00979693 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: psilocybin
Description: 4 mg psilocybin orally administered once during each of two day-long psychotherapy session
Study NCT01657799 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Veliparib
Description: Veliparib capsules for oral administration
Study NCT01657799 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo to veliparib capsules for oral administration
Study NCT01657799 — intervention group
Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: Whole brain radiation therapy
Description: 30.0 grays (Gy) of WBRT given in 10 daily fractions of 3.0 Gy each, excluding weekends and holidays
Study NCT01657799 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Whole brain radiation therapy
Description: 30.0 grays (Gy) of WBRT given in 10 daily fractions of 3.0 Gy each, excluding weekends and holidays
Study NCT01803334 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Marking abdomen
Description: If the patient is randomized to the marking the abdomen group (study group) she will then have the anticipated incision needed to place the trocars during her surgery marked on her abdomen by the surgeon attending physician involved in the patient care during the preoperative counseling visit.
Study NCT04400968 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Auricular therapy
Description: The auricular therapy points were selected following the protocol for dysmenorrhoea described by Oleson (Oleson, 2008). These points were (the name of the European cartography is specified by the name of the point): Shenmen \[FT2\], uterus \[FT5\], sympathetic \[HI4\], kidney \[CS6\], heart \[CI4\], endocrine \[IT2\] and thalamus \[PC2\].
Study NCT04400968 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: kinesio tape
Description: Before the tape application, the skin surface was removed of hair when needed and cleansed. The tapes were applied at 25% of tension and were placed horizontally covering the area between the antero-superior iliac spines and the postero-superior iliac spines and vertically from the navel to the symphysis pubis. All bandages were adhered to the skin with a technique type I with a space augmentation. The centre of the tape was removed and applied at 25% of tension. Afterwards, the rest of the protector were removed and the laterals anchors of the tape were adhered with no tension. The participant maintained a slight extension of the trunk while the tape was applied on the anterior aspect of the truck and a slight flexion while the tape was applied in the posterior aspect of the trunk.
Study NCT04400968 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Auricular therapy Placebo group
Description: Sham auricular therapy
Study NCT04400968 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: kinesio tape Placebo group
Description: Sham kinesio tape
Study NCT03931993 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo comparator
Study NCT03931993 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Grass MATA MPL
Study NCT03155854 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pretendinous cord excision
Description: The cord/palmar fascia will be excised during surgery.
Study NCT03155854 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Division/manipulation of the cord
Description: The pretendinous cord will be divided and incised during surgery.
Study NCT03622255 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: MINST
Description: Minimally invasive non-surgical technique (MINST) for the treatment of intrabony defects has been compared with minimally invasive surgical treatment of these defects and has shown to achieve similar beneficial clinical results. In this study MINST will be used as the control treatment.
Study NCT03622255 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: MINST with EMD
Description: Enamel matrix derivative (EMD) has been widely used in the surgical treatment of periodontal intrabony defects, using a minimally invasive surgical technique (MINST). Recent studies have suggested that this product could also be used in the non-surgical treatment of intrabony defects using a minimally invasive technique with very good results. This study will evaluate the effect of enamel matrix derivative in the non-surgical treatment of periodontal intrabony defects when a minimally invasive technique is used. Besides clinical measurements, radiographic analysis will also be performed to evaluate the treatment results.
Study NCT03282136 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Incretin Effect
Description: The patients will receive incretins therapy.
Study NCT03282136 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Cardiac Resynchronization therapy defibrillator device
Description: The patients will receive a Cardiac Resynchronization therapy defibrillator device
Study NCT03282136 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cardiac Resynchronization therapy defibrillator device
Description: The patients will receive a Cardiac Resynchronization therapy defibrillator device
Study NCT04515056 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Papain 10 µg
Description: The area will be exposed to 10 µg of papain.
Study NCT04515056 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Papain 50 µg
Description: The area will be exposed to 50 µg of papain.
Study NCT04515056 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Papain 100 µg
Description: The area will be exposed to 100 µg of papain.
Study NCT04515056 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vehicle
Description: The area will be exposed to vehicle
Study NCT04515056 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Papain 1 SPT
Description: Papain will be applied by 1 SPT prick thought the skin
Study NCT04515056 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Papain 5 SPT
Description: Papain will be applied by 5 SPT pricks thought the skin
Study NCT04515056 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Papain 25 SPT
Description: Papain will be applied by 25 SPT pricks thought the skin
Study NCT04515056 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cowhage
Description: The last area will be exposed to cowage spicules (made chemically inert by autoclaving) soaked in 5 mg/ml papain solution.
Study NCT02367430 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Critical Time Intervention With Buried in Treasures included
Description: Critical Time Intervention and BIT Workshop
Study NCT01928667 — intervention group
Intervention type: OTHER
Intervention: Whole saliva sample
Description: Both case and control group will be approached to consider to give permission to sample saliva. This is not obligatory. Collected samples will be stored for future DNA research.
Study NCT03704506 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Reyanning mixture
Description: Reyanning mixture , 20ml by mouth , 3 times per day for 7 days
Study NCT03704506 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: amoxil capsule
Description: amoxil capsule , 0.5g by mouth , 3 times per day for 7 days
Study NCT04456647 — intervention group
Intervention type: OTHER
Intervention: Parenteral nutrition
Description: Parenteral nutrition treatment in palliative care
Study NCT01041989 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutritional guidance
Description: Individual counseling sessions and group meetings will be organized.
Study NCT01041989 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Guided muscle strength training and aerobic exercise.